ARCHIVES

Groups’ Growth, Impact Shown by Five-Year Data

This article is from The Cancer Letter archive.

Vol. 04 No. 09 | March 3, 1978

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Drug Development Gets Extra $500,000

November 18, 1977

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006